NEUCA S.A.
Research NEUCA S.A. (7HD) on Bullrun: market cap EUR 783.35M, P/E 19.5, dividend yield 2.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7HD
- ExchangeF
- CountryPoland
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyEUR
- Market capEUR 783.35M
- P/E19.5
- Dividend yield2.4%
- Financial periodQ1 2026
- RevenuePLN 3.56B
- Net incomePLN 68.34M
- Free cash flow-PLN 29.73M
- Gross margin12.0%
Valuation Snapshot
latest market cap is EUR 783.35M; P/E is 19.5; dividend yield is 2.4%.
Peer valuation comparison
Latest P/E is 19.5x versus a Healthcare sector median of 24.46x (20.3% below).
Latest dividend yield is 2.37% versus a Healthcare sector median of 2.11% (12.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | PLN 13.64B | PLN 155.58M | PLN 423.99M | 11.4% | n/a | PLN 137.92M | PLN 501.81M | PLN 1.06B |
| FY2022 | PLN 11.23B | PLN 147.59M | n/a | 11.1% | 29.8 | PLN 208.42M | PLN 5.86M | PLN 880.24M |
| FY2021 | PLN 9.86B | PLN 152.55M | n/a | 10.4% | 32.51 | PLN 64.56M | PLN 4.74M | PLN 842.46M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 783.35M | 19.5 | 2.4% | 4.15 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 4.15 EUR, yield 2.4%.
| Year | Dividends/share |
|---|---|
| FY2022 | 2.71 PLN |
| FY2021 | 2.36 PLN |
About NEUCA S.A.
NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NEUCA S.A.'s market cap?
NEUCA S.A.'s market capitalization is EUR 783.35M.
What is NEUCA S.A.'s P/E ratio?
NEUCA S.A.'s price-to-earnings (P/E) ratio is 19.5.
Does NEUCA S.A. pay a dividend?
NEUCA S.A. has a dividend yield of 2.4%.
What does NEUCA S.A. do?
NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands.